Arch Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arch Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2014 to Q2 2024.
  • Arch Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -730 %, a 138% decline year-over-year.
  • Arch Therapeutics, Inc. annual Return On Assets for 2023 was -362 %, a 39.9% decline from 2022.
  • Arch Therapeutics, Inc. annual Return On Assets for 2022 was -259 %, a 82.6% decline from 2021.
  • Arch Therapeutics, Inc. annual Return On Assets for 2021 was -142 %, a 11.1% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -730 -423 -138% Apr 1, 2024 Jun 30, 2024
Q1 2024 -490 -221 -81.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -453 -185 -68.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -362 -103 -39.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -307 -83.5 -37.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -269 -91.2 -51.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -269 -122 -83% Oct 1, 2022 Dec 31, 2022
Q3 2022 -259 -117 -82.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -223 -77.4 -53% Apr 1, 2022 Jun 30, 2022
Q1 2022 -178 -31.1 -21.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -147 +15.4 +9.51% Oct 1, 2021 Dec 31, 2021
Q3 2021 -142 +17.7 +11.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -146 -14.2 -10.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -147 -9.91 -7.23% Jan 1, 2021 Mar 31, 2021
Q4 2020 -162 -48.6 -42.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -159 -16.7 -11.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -132 +8.66 +6.17% Apr 1, 2020 Jun 30, 2020
Q1 2020 -137 +1.8 +1.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -114 +54.6 +32.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -143 -46.1 -47.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -140 -24.8 -21.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -139 -30.2 -27.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -168 -72.5 -75.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -96.5 +33.9 +26% Jul 1, 2018 Sep 30, 2018
Q2 2018 -116 +4.14 +3.46% Apr 1, 2018 Jun 30, 2018
Q1 2018 -109 +13 +10.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -95.8 +53.5 +35.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -130 +22.5 +14.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -120 +42.6 +26.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -122 +42.4 +25.9% Jan 1, 2017 Mar 31, 2017
Q4 2016 -149 +16.8 +10.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -153 -18.2 -13.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -162 -120 -285% Apr 1, 2016 Jun 30, 2016
Q1 2016 -164 -221 -388% Jan 1, 2016 Mar 31, 2016
Q4 2015 -166 +282 +62.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -135 +376 +73.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -42.1 +507 +92.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 57.1 +801 Jan 1, 2015 Mar 31, 2015
Q4 2014 -448 Oct 1, 2014 Dec 31, 2014
Q3 2014 -511 Jul 1, 2014 Sep 30, 2014
Q2 2014 -549 Apr 1, 2014 Jun 30, 2014
Q1 2014 -744 Jan 1, 2014 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.